Cytokinetics pharmaceuticals stock
WebApr 5, 2024 · CYTOKINETICS, INCORPORATED : News, information and stories for CYTOKINETICS, INCORPORATED Nasdaq: CYTK Nasdaq ... VERTEX PHARMACEUTICALS INCORPORATED : Q1 2024 Earnings Release (Projected) 05/04/23: ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ WebApr 15, 2024 · On April 12, 2024, Mark A. Schlossberg, Senior Vice President, Legal, General Counsel and Secretary of Cytokinetics, Incorporated, informed Cytokinetics that he would be retiring from the company... April 12, 2024 ... REGENERON PHARMACEUTICALS, INC. 13.71%: 87 477: VERTEX PHARMACEUTICALS …
Cytokinetics pharmaceuticals stock
Did you know?
WebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebMar 4, 2024 · The most optimistic Cytokinetics analyst has a price target of US$75.00 per share, while the most pessimistic values it at US$46.00. Analysts definitely have varying views on the business, but...
WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ... WebJul 1, 2024 · The initial conversion price represents a premium of 30.0% over the last reported sale price of $39.29 per share of Cytokinetics’ common stock on June 30, 2024. The conversion rate and...
WebMar 31, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function. WebJul 19, 2024 · Shares of the little biotech firm Cytokinetics jumped by as much as 60% Monday morning, on the results from a study of the firm’s investigational drug for a …
WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The institutional investor owned 961 shares of the biopharmaceutical …
WebNov 8, 2024 · Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional $18.0 million aggregate principal amount of the notes in connection with the offering, solely to cover... foamex display boardsWebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... greenwich to leicester squareWebApr 10, 2024 · The company’s shares closed last Thursday at $78.78. Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to... foam explosion in backyardWebJan 7, 2024 · Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million. Royalty Pharma Extends Capitalto Cytokineticsto Support the Commercial Launch of Omecamtiv Mecarbil and the Further Developmentof Aficamten. Royalty Pharma Purchases Royalties on Future Sales of Aficamten. foam exercise mats interlockingWebMar 7, 2024 · Cytokinetics (Nasdaq:CYTK) earnings and revenue forecasts, price targets, future return on equity. ... President & Director exercised options and sold US$333k worth of stock Aug 04. Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M ... High growth companies in the Pharmaceuticals & Biotech industry. greenwich to kings cross tubeWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … foam exercise roller 36 inchWebApr 29, 2004 · Cytokinetics is registered under the ticker NASDAQ:CYTK . Their stock opened with $13.00 in its Apr 29, 2004 IPO. Cytokinetics is funded by 5 investors. Royalty Pharma and Deerfield are the most recent investors. Cytokinetics has invested in The Mended Hearts on Jan 30, 2024. This investment - Grant - The Mended Hearts - was … greenwich to liverpool street station